NASDAQ:MGEN
Delisted
Miragen Therapeutics, Inc. Stock News
$17.64
+0 (+0%)
At Close: Aug 17, 2022
Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
08:32pm, Thursday, 23'rd Jul 2020
BOULDER, Colo., July 23, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapi
miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020
12:00pm, Wednesday, 22'nd Jul 2020
BOULDER, Colo., July 22, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapi
Miragen Therapeutics (NASDAQ:MGEN) Downgraded by Zacks Investment Research to Hold
06:38pm, Wednesday, 15'th Jul 2020
Miragen Therapeutics (NASDAQ:MGEN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.c
miRagen Regains Compliance With Nasdaq Listing Requirements
08:15pm, Thursday, 02'nd Jul 2020
BOULDER, Colo., July 02, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to
H.C. Wainwright Thinks Neovasc's Stock is Going to Recover - Markets
10:13am, Thursday, 02'nd Jul 2020
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Neovasc (NVCN – Research Report) today and set a price
Cel-Sci (CVM) Receives a Buy from H.C. Wainwright - Markets
10:18am, Monday, 29'th Jun 2020
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Cel-Sci (CVM – Research Report),
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novan (NOVN
Miragen Therapeutics (NASDAQ:MGEN) Trading Down 8.2%
06:04am, Friday, 26'th Jun 2020
Miragen Therapeutics Inc (NASDAQ:MGEN)’s stock price fell 8.2% during mid-day trading on Wednesday . The company traded as low as $1.11 and last traded at $1.12, 28,655 shares were traded during mid
Are We Together in Battle Against Coronavirus? Report Shows Minorities Faced Increased Violence
05:41am, Thursday, 25'th Jun 2020
This year’s Peoples Under Threat index underscores how minority and indigenous communities faced more violence and health risk during the times of Coronavirus.
Stocks To Hedge Your Portfolio With Amid Rising Coronavirus Cases
12:00am, Thursday, 25'th Jun 2020
If you’re looking to hedge against a coming pullback in the markets, we've used our deep learning algorithms and AI to identify the Top Shorts today.
Miragen Therapeutics (NASDAQ:MGEN) Trading Up 13.8%
06:14am, Wednesday, 24'th Jun 2020
Miragen Therapeutics Inc (NASDAQ:MGEN) shares traded up 13.8% during mid-day trading on Monday . The stock traded as high as $1.36 and last traded at $1.45, 120,694 shares changed hands during mid-day
The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) * ADC Therapeutics SA (NYSE: ADCT) * Adver
Why Shares of Translate Bio Are Surging Higher
12:00am, Tuesday, 23'rd Jun 2020
Shares of the small-cap mRNA therapeutics company Translate Bio Inc (NASDAQ: TBIO) were ripping higher Tuesday.
What Happened: Translate Bio and Sanofi SA (NASDAQ: SNY)...
BOULDER, Colo., June 22, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to
Analysts Anticipate Miragen Therapeutics Inc (NASDAQ:MGEN) Will Announce Earnings of -$0.15 Per Share
03:14am, Monday, 22'nd Jun 2020
Analysts expect Miragen Therapeutics Inc (NASDAQ:MGEN) to report earnings per share (EPS) of ($0.15) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Mira
